Dermata Therapeutics, Inc.
DRMA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001853816
No open-market purchases or sales by Dermata Therapeutics, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $158.0K in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Dermata Therapeutics, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 11 | 4 | −7 |
| Shares | 292.8K | 37.2K | −255.6K (−87.3%) |
| Value | $118.8K | $47.4K | −$71.4K (−60.1%) |
New holders (1)
Institutions that held Dermata Therapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 26,400 | $34.0K | 0.00% |
Sold out (8)
Institutions that held Dermata Therapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Raymond James Financial Services Advisors, Inc. | 141,763 | $58.0K |
| Geode Capital Management, LLC | 26,666 | $10.0K |
| Financial Advisory Service, Inc. | 12,698 | $5.19K |
| Two Sigma Securities, LLC | 12,434 | $5.09K |
| Sage Capital Advisors,llc | 12,000 | $4.91K |
| HC Advisors, LLC | 10,000 | $4.09K |
| Tudor Investment Corp Et Al | 10,205 | $4.00K |
| Morgan Stanley | 562 | $230 |